Evidence map›Paper›PMID 38934543›Full record

ArticlemSystems2024

PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides.

Marc Ramos-Llorens, Roberto Bello-Madruga, Javier Valle, David Andreu, Marc Torrent

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marc Ramos-LlorensSystems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-5194-1279
Roberto Bello-MadrugaSystems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0009-0003-8474-3951
Javier ValleBarcelona Biomedical Research Park, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
David AndreuBarcelona Biomedical Research Park, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-6317-6666
Marc TorrentSystems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-6567-3474

Funding

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) ESCMID2022La Caixa Health Foundation HR17-00409Ministerio de Ciencia e Innovación (MCIN) PDC2021-121544-I00/AEI/10.13039/501100011033Ministerio de Ciencia e Innovación (MCIN) PID2020-113184RB-C22/AEI/10.13039/501100011033Ministerio de Ciencia e Innovación (MCIN) PID2020-114627RB-I00/AEI/10.13039/501100011033
6 · The paper itself

Abstract

The alarming rise of antibiotic-resistant bacterial infections is driving efforts to develop alternatives to conventional antibiotics. In this context, antimicrobial peptides (AMPs) have emerged as promising candidates for their ability to target a broad range of microorganisms. However, the development of AMPs with optimal potency, selectivity, and/or stability profiles remains a challenge. To address it, computational tools for predicting AMP properties and designing novel peptides have gained increasing attention. PyAMPA is a novel platform for AMP discovery. It consists of five modules, namely AMPScreen, AMPValidate, AMPSolve, AMPMutate, and AMPOptimize, that allow high-throughput proteome inspection, candidate screening, and optimization through point-mutation and genetic algorithms. The platform also offers additional tools for predicting and evaluating AMP properties, including antimicrobial and cytotoxic activity, and peptide half-life. By providing innovative and accessible inroads into AMP motifs in proteomes, PyAMPA will enable advances in AMP development and potential translation into clinically useful molecules. PyAMPA is available at: https://github.com/SysBioUAB/PyAMPA. IMPORTANCE: This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance.

Indexed as

Antimicrobial PeptidesAlgorithmsAnti-Bacterial AgentsHigh-Throughput Screening AssaysHumansMicrobial Sensitivity TestsSoftwareAnti-Bacterial AgentsAntimicrobial Peptidesantimicrobial peptide

Identifiers

PMID38934543
PMCPMC11264690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.